Singapore markets open in 6 hours 58 minutes
Straits Times Index
3,338.57 +5.77 (+0.17%) S&P 500
5,467.02 +6.54 (+0.12%) Dow
39,163.99 +45.13 (+0.12%) Nasdaq
17,822.64 +90.04 (+0.51%) Bitcoin USD
63,577.11 +1,970.65 (+3.20%) CMC Crypto 200
1,315.58 +13.51 (+1.04%)
PTCT Sep 2024 37.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:51AM EDT. Market open.
| Previous close | 5.75 |
| Open | N/A |
| Bid | 0.00 |
| Ask | 3.00 |
| Strike | 37.00 |
| Expiry date | 2024-09-20 |
| Day's range | 5.75 - 5.75 |
| Contract range | N/A |
| Volume | |
| Open interest | 2 |
ZacksPTC Therapeutics (PTCT) Down on Negative CHMP Opinion on DMD Drug
PTC Therapeutics (PTCT) falls as the EC's advisory committee adopts a negative opinion regarding the renewal of the conditional marketing approval of Translarna to treat nmDMD in the EU.
PR NewswireCHMP Issues Negative Opinion on Translarna™ Following European Commission Request for Review
PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the CHMP has issued a negative opinion on the renewal of the conditional marketing authorization of Translarna™ (ataluren) for the treatment of nmDMD. This opinion follows the return of the previously issued negative opinion by the European Commission (EC) for re-review.
ZacksPTC Therapeutics (PTCT) Soars 9.7%: Is Further Upside Left in the Stock?
PTC Therapeutics (PTCT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
© 2024 Yahoo. All rights reserved.